Quantcast

Latest Gonadotropin-releasing hormone agonist Stories

2014-01-13 12:28:06

LAUSANNE, Switzerland, January 13, 2014 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, announces that it has completed the recruitment of patients for its Phase III clinical study in Central Precocious Puberty (CPP) with triptorelin 22.5 mg. Debiopharm is investigating the efficacy and safety of...

2013-07-16 22:34:28

In a study that included more than 10,000 men with nonmetastatic prostate cancer, use of androgen deprivation therapy (ADT) was associated with a significantly increased risk of acute kidney injury, with variations observed with certain types of ADTs, according to a study in the July 17 issue of JAMA. "Androgen deprivation therapy is the mainstay treatment for patients with advanced prostate cancer. While this therapy has been traditionally reserved for patients with advanced disease, ADT...

2013-01-18 23:00:32

Endometriosis is a painful, sometimes disabling disease that attacks a woman´s reproductive tract and can ultimately lead to infertility and chronic pelvic pain (CPP). Dr. Jonathan Zaidan MD and Debbie Henry, NP-C, have collaborated to provide comprehensive assessment, diagnosis, treatment, and management for women with diagnosed endometriosis and those suffering from chronic pelvic pain (CPP). Rochester, MI (PRWEB) January 18, 2013 For over a decade, Dr. Jonathan Zaidan MD has been...

2012-08-10 02:48:45

Women with uterine fibroids larger than 10 cm have a new nonsurgical treatment choice —hormone acting drugs followed by uterine artery embolization, a new study shows. The new treatment option can replace hysterectomy, which leaves women infertile. The study, conducted at the Yonsei University College of Medicine in Seoul South Korea, included 40 women with 10 cm or larger uterine fibroids. Twelve of the women received gonadotropin-releasing hormone (GnRH) agonists to shrink their...

2011-08-16 14:19:00

ABBOTT PARK, Ill., Aug. 16, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved two new strengths for three-month administration of Lupron Depot-PED ® (leuprolide acetate for depot suspension) for the treatment of children with central precocious puberty (CPP). CPP is a condition that causes children to enter puberty too soon, resulting in the development and progression of secondary sex characteristics...

2011-07-20 02:12:29

Temporarily suppressing ovarian function with use of the hormone analogue triptorelin reduced the occurrence of early menopause induced by chemotherapy among women with breast cancer, according to a study in the July 20 issue of JAMA. Approximately 6 percent of women with breast cancer are diagnosed before age 40 years, with the majority of young patients receiving systemic treatment with chemotherapy, hormonal therapy, or both. Chemotherapy regimens are associated with an incidence of...

2011-06-20 08:00:00

ABBOTT PARK, Ill., June 20, 2011 /PRNewswire/ -- Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved a new 45 mg for six-month administration formulation of Lupron Depot® (leuprolide acetate for depot suspension), a medication used for the palliative treatment of advanced prostate cancer. "Lupron Depot is an important treatment option for many patients with advanced prostate cancer," said Eugene Sun, M.D., vice president, Global...

2011-06-06 14:39:39

Men with prostate cancer are at higher risk of developing diabetes or diabetes risk factors if they receive androgen deprivation therapy (ADT) to block the production or action of male hormones that can fuel the growth of this cancer. The results of this new study on the second-most common cancer in men are being presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston. "These patients may benefit from counseling, screening and closer monitoring for the development of these...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.